Table 6.
Calcium Intake Quintile | Difference in Agatston Unitsa | 95% CI Limits | P Value |
---|---|---|---|
Model 1b | |||
Q1: <434.9 | 0 | Reference | — |
Q2: 434.9–650.7 | −15.45 | −76.5 to 45.6 | 0.62 |
Q3: 650.7–936.5 | −19.69 | −80.7 to 41.3 | 0.53 |
Q4: 936.5–1453.5 | −31.78 | −94.3 to 30.7 | 0.32 |
Q5: ≥1453.5 | −7.84 | −71.4 to 55.7 | 0.81 |
Model 2c | |||
Q1: <434.9 | 0 | Reference | — |
Q2: 434.9–650.7 | −31.95 | −95.2 to 31.3 | 0.32 |
Q3: 650.7–936.5 | −45.16 | −113.7 to 23.4 | 0.20 |
Q4: 936.5–1453.5 | −59.33 | −133.3 to 14.6 | 0.12 |
Q5: ≥1453.5 | −51.00 | −133.6 to 31.6 | 0.23 |
BMI indicates body mass index; BP, blood pressure; CAC, coronary artery calcium; eGFR, estimated glomerular filtration rate; HDL, high‐density lipoprotein; MESA, the Multi‐Ethnic Study of Atherosclerosis.
Log transformed.
Model 1 adjusted for age, sex, race/ethnicity, site, BMI, exercise, smoking, pack‐years, alcohol, education, income, health insurance, and total caloric intake.
Model 2 adjusted for model 1 variables+systolic BP, diastolic BP, family history of heart disease, total cholesterol, HDL‐cholesterol, lipid‐lowering medication use, diabetes mellitus, eGFR, total homocysteine, current aspirin use, and calcium supplement use.